CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02104219
NCT02104219N/ACompleted

A Retrospective, Non-interventional, Epidemiologic Study of the Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)

Alexion Pharmaceuticals, Inc.·observational·Posted Apr 4, 2014·Updated Apr 1, 2019

In Brief

An observational study for Hypophosphatasia (HPP). Completed, enrolled 32 participants across 19 sites in 8 countries.

Detailed Summary

The purpose of this study is to characterize the natural history of HPP in patients with Juvenile-onset HPP.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, Canada, France, Netherlands, Russia, Turkey (Türkiye), United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 4, 2014
Enrollment StartMar 1, 2014
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 12.2 years ago